Key Details
Price
$24.46Last Dividend
$0.64TTM Dividend Yield
2.63%PE Ratio
20.03Annual ROE
3.28%Beta
0.36Events Calendar
Next earnings date:
Feb 20, 2025Recent quarterly earnings:
Nov 5, 2024Recent annual earnings:
Feb 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
May 17, 2024Next split:
N/ARecent split:
Dec 4, 2012Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Fresenius Medical Care is a top company in kidney care worldwide, experiencing notable growth with an 18.5% rise since my previous article. The company is reasonably priced, with a price-to-earnings ratio of under 18.5 and a fair value estimate of at least $34 per share. While there are risks related to US healthcare politics and technology changes, the company's diverse offerings and home-care approach are significant advantages.
Fresenius (FMS) has received a Zacks Rank #1 (Strong Buy) upgrade, indicating increased confidence in the company's potential earnings. This could lead to a rise in the stock price soon.
On January 7, 2024, PRMB, FMS, and RBA were included in the Zacks Rank #1 (Strong Buy) list of income stocks.
On December 27, 2024, PAYO, TTDKY, and FMS were included in the Zacks Rank #1 (Strong Buy) list of momentum stocks.
BAD HOMBURG, Germany, Dec. 20, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), a top provider of products and services for kidney disease, will rejoin the DAX 40, Germany's main stock index, starting December 27, 2024. This index tracks the performance of the 40 largest publicly traded companies on the Frankfurt Stock Exchange and represents about 80 percent of the market value of listed companies in Germany.
Fresenius Medical Care is a top provider of dialysis services worldwide, focusing on growth through new ideas, reorganizing its operations, and having a strong presence in over 120 countries.
At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. However, we also keep an eye on the most recent trends in value, growth, and momentum to support our top selections.
No matter if you invest in value, growth, or momentum stocks, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key features of the Zacks Premium research service.
Fresenius Medical Care AG (NYSE:FMS) will hold its Q3 2024 Earnings Conference Call on November 5, 2024, at 8:00 AM ET. Key participants from the company include Dominik Heger, Helen Giza, and Martin Fischer. The call will also feature analysts from various financial institutions, and the operator, Sandra, will welcome everyone to the event.
In the third quarter, we saw a 2% increase in organic revenue, driven by improvements in Care Enablement and Care Delivery. The U.S. dialysis treatment volume growth has turned positive, and we exceeded our savings target for the year, adding an extra EUR 64 million in the third quarter. Both segments have also improved their operating income and margins, with a positive outlook for operating income growth in FY 2024.
FAQ
- What is the ticker symbol for Fresenius Medical Care AG & Co KGaA?
- Does Fresenius Medical Care AG & Co KGaA pay dividends?
- What sector is Fresenius Medical Care AG & Co KGaA in?
- What industry is Fresenius Medical Care AG & Co KGaA in?
- What country is Fresenius Medical Care AG & Co KGaA based in?
- When did Fresenius Medical Care AG & Co KGaA go public?
- Is Fresenius Medical Care AG & Co KGaA in the S&P 500?
- Is Fresenius Medical Care AG & Co KGaA in the NASDAQ 100?
- Is Fresenius Medical Care AG & Co KGaA in the Dow Jones?
- When was Fresenius Medical Care AG & Co KGaA's last earnings report?
- When does Fresenius Medical Care AG & Co KGaA report earnings?